Malik Shahzil Abdur Rehman, Ali Jamshed, Javed Maleeha, Hussain Kamran, Azeem Navaira, Rehman Nasir, Faheem Osman
Medical College, Aga Khan University, Karachi, Pakistan.
Section of Cardiology, Department of Medicine, Aga Khan University, Karachi, Pakistan.
Front Cardiovasc Med. 2025 Feb 6;12:1513802. doi: 10.3389/fcvm.2025.1513802. eCollection 2025.
Small aortic annulus poses a major challenge in aortic valve replacement due to the increased risk of prosthesis-patient mismatch (PPM) and increased surgical risk. In recent years, transcatheter aortic valve replacement (TAVR) has emerged as a popular alternative to the traditional surgical aortic valve replacement. We present the case of an 80-year-old woman with a small aortic annulus who underwent TAVR using a self-expanding transcatheter heart valve Acurate Neo2 after an non-ST-segment elevation myocardial infarction (NSTEMI) presentation. These risks, combined with advanced age, significant co-morbidities, and a severely calcified small aortic annulus, supported the choice of TAVR with a self-expanding Acurate Neo2 valve. Despite multiple risk factors for PPM, the patient had a successful outcome without major complications. Our case highlights the off-label use of the Acurate Neo2 valve in one of the smallest aortic annuli reported to date, showcasing its feasibility in Asian and resource-limited settings.
小主动脉瓣环在主动脉瓣置换术中是一个重大挑战,因为人工瓣膜与患者不匹配(PPM)的风险增加,手术风险也增加。近年来,经导管主动脉瓣置换术(TAVR)已成为传统外科主动脉瓣置换术的一种流行替代方案。我们介绍了一名80岁小主动脉瓣环女性的病例,该患者在出现非ST段抬高型心肌梗死(NSTEMI)后,使用自膨胀式经导管心脏瓣膜Acurate Neo2进行了TAVR。这些风险,再加上高龄、严重的合并症以及严重钙化的小主动脉瓣环,支持了选择使用自膨胀式Acurate Neo2瓣膜进行TAVR。尽管存在多种PPM风险因素,但患者取得了成功的结果,没有出现重大并发症。我们的病例突出了Acurate Neo2瓣膜在迄今为止报道的最小主动脉瓣环之一中的超说明书使用,展示了其在亚洲和资源有限环境中的可行性。